TLR2 affects CD86 expression and inflammatory response in burn injury mice through regulation of p38

Area of Science:

• Immunology
• Molecular Biology
• Pathology

Background:

• Burn injuries trigger significant inflammatory responses.
• Toll-like receptor 2 (TLR2) and its downstream signaling pathways are implicated in inflammation.
• The specific role of the TLR2-p38-CD86 axis in burn injury-induced inflammation requires elucidation.

Purpose of the Study:

• To investigate the involvement of the TLR2-p38-CD86 signaling pathway in the inflammatory response following burn injury in a mouse model.
• To determine the impact of TLR2 and p38 modulation on key inflammatory mediators and apoptosis.

Main Methods:

• Construction of a mouse model of burn injury using wild-type (TLR2^+/+) and knockout (TLR2^-/-) mice.
• Histological analysis (Hematoxylin and eosin, TUNEL assay) of tissue samples.
• In vitro treatment of macrophages with TLR2 agonist and p38 inhibitor.
• Quantification of gene and protein expression (TLR2, p38, CD86, IL-1β, TNF-α) using RT-qPCR, Western blot, and ELISA.

Main Results:

• Burn injury significantly increased apoptosis and the expression of TLR2, p38, CD86, IL-1β, and TNF-α compared to sham controls.
• Inhibition of TLR2 reduced p-p38, CD86, IL-1β, and TNF-α expression.
• In vitro, TLR2 agonist upregulated p-p38, CD86, IL-1β, and TNF-α, while a p38 inhibitor decreased CD86, IL-1β, and TNF-α expression.

Conclusions:

• The TLR2-p38-CD86 signaling pathway is a critical regulator of inflammation in burn injury.
• Targeting this pathway holds potential for therapeutic intervention in burn-related inflammatory conditions.